Andreas G. Frank Sells 6,870 Shares of Hill-Rom Holdings, Inc. (HRC) Stock
Hill-Rom Holdings, Inc. (NYSE:HRC) SVP Andreas G. Frank sold 6,870 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the sale, the senior vice president now owns 16,701 shares in the company, valued at $1,293,993.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Hill-Rom Holdings, Inc. (HRC) traded down 1.81% during midday trading on Friday, hitting $75.60. The stock had a trading volume of 1,612,576 shares. Hill-Rom Holdings, Inc. has a 12 month low of $50.50 and a 12 month high of $84.65. The stock has a 50 day moving average of $75.42 and a 200 day moving average of $75.05. The stock has a market cap of $4.98 billion, a price-to-earnings ratio of 44.06 and a beta of 1.21.
Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a net margin of 0.83% and a return on equity of 1.90%. The company had revenue of $689.10 million for the quarter, compared to the consensus estimate of $695.50 million. During the same quarter last year, the firm posted $0.81 earnings per share. Hill-Rom Holdings’s revenue was up 5.1% on a year-over-year basis. Analysts expect that Hill-Rom Holdings, Inc. will post $3.82 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.95%. The ex-dividend date of this dividend is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio (DPR) is 41.62%.
TRADEMARK VIOLATION NOTICE: This report was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/09/15/andreas-g-frank-sells-6870-shares-of-hill-rom-holdings-inc-hrc-stock.html.
A number of institutional investors have recently added to or reduced their stakes in the stock. Canada Pension Plan Investment Board grew its holdings in Hill-Rom Holdings by 42.7% during the 2nd quarter. Canada Pension Plan Investment Board now owns 16,700 shares of the medical technology company’s stock worth $1,329,000 after acquiring an additional 5,000 shares in the last quarter. Chase Investment Counsel Corp acquired a new position in shares of Hill-Rom Holdings in the 2nd quarter valued at about $675,000. American Century Companies Inc. boosted its holdings in shares of Hill-Rom Holdings by 1,191.1% in the 2nd quarter. American Century Companies Inc. now owns 110,359 shares of the medical technology company’s stock valued at $8,786,000 after buying an additional 101,811 shares during the period. Brookstone Capital Management acquired a new position in shares of Hill-Rom Holdings in the 2nd quarter valued at about $289,000. Finally, Royce & Associates LP boosted its holdings in shares of Hill-Rom Holdings by 23.6% in the 1st quarter. Royce & Associates LP now owns 397,547 shares of the medical technology company’s stock valued at $28,067,000 after buying an additional 75,900 shares during the period. 82.31% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities research analysts have issued reports on the company. Zacks Investment Research upgraded Hill-Rom Holdings from a “sell” rating to a “hold” rating in a research report on Thursday, August 24th. BidaskClub upgraded Hill-Rom Holdings from a “sell” rating to a “hold” rating in a report on Sunday, August 6th. Stifel Nicolaus reiterated a “buy” rating and issued a $84.00 price target on shares of Hill-Rom Holdings in a report on Sunday, July 30th. Cantor Fitzgerald set a $86.00 price target on Hill-Rom Holdings and gave the stock a “hold” rating in a report on Friday, July 28th. Finally, Needham & Company LLC dropped their price objective on Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating on the stock in a research note on Friday, July 28th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $88.17.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.